House Bill 5794
116th Congress(2019-2020)
Endometrial Cancer Research and Education Act of 2020
Introduced
Introduced in House on Feb 6, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5794
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
David Scott
grade
Georgia
California
California
Delaware
District of Columbia
Florida
Florida
Georgia
Georgia
Illinois
Illinois
Illinois
Indiana
Louisiana
Maryland
Massachusetts
Mississippi
New Jersey
New Jersey
New York
New York
New York
North Carolina
Ohio
Ohio
South Carolina
Tennessee
Texas
Texas
U.S. Virgin Islands
No House votes have been held for this bill.
Summary
Endometrial Cancer Research and Education Act of 2020
This bill requires the National Institutes of Health and the Centers for Disease Control and Prevention to expand research and develop certain educational materials on endometrial cancer, respectively. Among other issues, the materials must address certain endometrial cancer disparities and risk factors that affect minority women.
February 6, 2020
02/06/2020
Referred to the House Committee on Energy and Commerce.
02/06/2020
Introduced in House
Public Record
Record Updated
Feb 8, 2022 11:15:06 PM